Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in Sao Paulo, Brazil

Imagem de Miniatura
Arquivos
art_WOZNIAK_Factors_associated_with_attitudes_towards_HIV_cure_research_2020.PDF (389.75 KB)
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMJ PUBLISHING GROUP
Autores
WOZNIAK, Robert J.
MAHAFE, Bianca
BARROS, Daniel A. C.
MEDEIROS, Edmilson Alves de
ROGGENBUCK, Albert
Citação
BMJ OPEN, v.10, n.11, article ID e040092, 17p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective Characterising the perceptions of groups most affected by HIV is fundamental in establishing guidelines for biomedical advancement. Although Brazil has successfully fought HIV/AIDS through several measures, transgender women still have a likelihood of HIV infection 55 times higher than the general population. This study aimed to better understand the perception and awareness of HIV cure research among the trans-identifying population in Sao Paulo, Brazil, and to determine factors that motivate or discourage participation in HIV cure studies. Setting This cross-sectional study analysed data collected from a questionnaire administered to 118 transgender women and travestis at 5 sites within the city of Sao Paulo. It uses quantitative methodology to describe the perspectives of transgender and travesti people in relation to HIV cure research and the context in which such perspectives are produced. Results Of 118 participants, most participants (73%) had some knowledge of HIV cure research and were most willing to participate in online surveys (52%), interviews (52%), focus groups (52%) and studies involving blood draws (57%). Those with a higher education or employment status were more likely to agree that someone had been cured of HIV, people living with HIV are discriminated against, and more information about HIV cure research is needed before the community embraces it. Only 55% of participants completely trusted their physician. The biggest motivational factors included gaining additional knowledge about HIV infection (77%) and the potential for a longer, healthier life for all (73%). Conclusions As a primary analysis of HIV cure attitudes among the transgender and travesti population as well as the social context in which they are formed, this study identifies opportunities to strengthen the dialogue and develop more educational collaborations between scientific investigators, community educators and the trans-identifying population to ensure that HIV cure research is inclusive of diverse perspectives.
Palavras-chave
epidemiology, health &amp, safety, international health services, quality in health care, HIV &amp, AIDS, public health
URI
https://observatorio.fm.usp.br/handle/OPI/39233
Referências
  1. Andrade FCD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196494
  2. Arnold MP, 2015, J VIRUS ERAD, V1, P43
  3. Baral S, 2019, LANCET HIV, V6, pE632, DOI 10.1016/S2352-3018(19)30226-7
  4. Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8
  5. Bastos FI, 2018, MEDICINE, V97, pS16, DOI [10.1097/MD.0000000000009447, 10.1097/md.0000000000009447]
  6. Batista Luís Eduardo, 2005, Ciênc. saúde coletiva, V10, P71, DOI 10.1590/S1413-81232005000100013
  7. Benotsch EG, 2016, INT J STD AIDS, V27, P776, DOI 10.1177/0956462415595319
  8. Benzaken AS, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0234-2
  9. Campuzano G, 2006, IDS BULL-I DEV STUD, V37, P34, DOI 10.1111/j.1759-5436.2006.tb00299.x
  10. Chin LJ, 2016, J EMPIR RES HUM RES, V11, P299, DOI 10.1177/1556264616679537
  11. Clutton GT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01452
  12. Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105
  13. Collier R, 2015, CAN MED ASSOC J, V187, pE493, DOI 10.1503/cmaj.109-5158
  14. Costa AB, 2018, J IMMIGR MINOR HEALT, V20, P115, DOI 10.1007/s10903-016-0527-7
  15. Costa AB, 2015, ARCH SEX BEHAV, V44, P521, DOI 10.1007/s10508-014-0386-z
  16. Cutuli Maria Soledad, 2012, SUDAMERICA REV CIENC, V1.1, P161
  17. da Silva MA, 2020, CIENC SAUDE COLETIVA, V25, P1723, DOI 10.1590/1413-81232020255.33082019
  18. Deuba K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58767-0
  19. Deutsch MB, 2015, LANCET HIV, V2, pE512, DOI 10.1016/S2352-3018(15)00206-4
  20. Dube K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25404
  21. Ferreira Ana Cristina Garcia, 2019, Transgend Health, V4, P107, DOI 10.1089/trgh.2018.0063
  22. Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS445, DOI 10.1590/S0102-311X2007001500012
  23. Giroir BP, 2020, AM J PUBLIC HEALTH, V110, P22, DOI 10.2105/AJPH.2019.305380
  24. Grant J.M., 2011, INJUSTICE EVERY TURN
  25. Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3
  26. Grinsztejn B, 2017, LANCET HIV, V4, pE169, DOI 10.1016/S2352-3018(17)30015-2
  27. Gupta RK, 2019, NATURE, V568, P244, DOI 10.1038/s41586-019-1027-4
  28. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  29. Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
  30. Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905
  31. Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010
  32. Jackson-Best F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5861-3
  33. Jalil EM, 2018, JAIDS-J ACQ IMM DEF, V79, P445, DOI 10.1097/QAI.0000000000001839
  34. Keller M, 2016, ENDING AIDS REACH VU, V14
  35. Krüger Alícia, 2019, Rev. bras. epidemiol., V22, pe190004, DOI 10.1590/1980-549720190004.supl.1
  36. Lopes Fernanda, 2007, Rev. Saúde Pública, V41, P39
  37. Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1
  38. Magno L, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00112718, 10.1590/0102-311X00112718]
  39. Martins TA, 2013, AIDS CARE, V25, P606, DOI 10.1080/09540121.2012.726342
  40. Norton AT, 2013, SEX ROLES, V68, P738, DOI 10.1007/s11199-011-0110-6
  41. Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255
  42. Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3
  43. Poteat T, 2013, SOC SCI MED, V84, P22, DOI 10.1016/j.socscimed.2013.02.019
  44. Power J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202647
  45. Saude BMda, 2018, PREVENCAO CONTROLE I
  46. Sevelius J, 2019, CULT HEALTH SEX, V21, P543, DOI 10.1080/13691058.2018.1496277
  47. Sylla L, 2018, AIDS RES HUM RETROV, V34, P56, DOI [10.1089/AID.2017.0178, 10.1089/aid.2017.0178]
  48. Tarimo EAM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2875-6
  49. Tullis T, 2013, MEASURING USER EXPER, V6, P121
  50. UNAIDS, 2014, 90 90 90 AMB TREATM
  51. Wilson Y, 2019, AM J BIOETHICS, V19, P8, DOI 10.1080/15265161.2018.1557275

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - LIM/60
Carregar mais